Clinical trials are considered a better method for treating esophageal cancer. The evaluation of new drugs, different combinations of treatments, new approaches to radiation therapy or surgery, and new therapies are integrated into clinical trials of esophageal cancer. New treatments with better efficacy and safety are the outcome of a clinical trial. The results of the clinical trials have been effective in reducing the symptoms and side effects during the treatment. Volunteers or patients willing to participate in the clinical trials should communicate with their doctor and healthcare team, and research expertise to make well decided informed choices regarding participating in the problem while signing informed consent. The volunteers willingly participate as they know the studies are a way to help advance the treatment of esophageal cancer. Eligibility criteria for esophageal clinical trials ensure that the participants are safe, bound to no ill effects, and well-structured research. People who take part in clinical trials of esophageal cancer may withdraw their participation at any moment in time due to any personal or medical conditions. It may be because the treatment is not working or giving the desired results, including severe risks and side effects.
Patient safety and informed consent
To join a clinical trial, people must participate in a process known as informed consent. During informed consent, the doctor should:
- Describe all of the treatment options, so that the person understands how the new treatment differs from the standard treatment.
- List all of the risks of the new treatment, which may or may not be different than the risks of standard treatment.
- Explain what will be required of each person in order to participate in the clinical trial, including the number of doctor visits, tests, and the schedule of treatment.
- Describe the purposes of the clinical trial and what researchers are trying to learn.
Clinical Trial of Esophageal Cancer
On the path to finding different ways to treat cancer, various research and trials have been carried out to find safe and effective treatments other than the standard ones. Every drug that is used now was once tested in clinical trials. The clinical studies mainly focus on finding a safe, effective, and better treatment or diagnostic procedure. They evaluate new chemotherapy or radiotherapy drugs for better treatment of cancer 1.
Taking part in clinical trials can benefit people by receiving treatment before it is available. As the coin has two sides, there are some risks with the clinical trials, including its side effects and the possibility of new clinical trials not working. Clinical trials are also conducted on drugs and other therapies that can relieve the symptoms and side effects of treatments like chemotherapy, radiotherapy, etc. 2. People are strongly encouraged to talk with their health care team about the pros and cons of joining a specific study.
Participating in clinical trials can have many reasons. For some people, taking part in a clinical trial is the only option to receive the best treatment for the type of cancer. Because standard treatments are not perfect, people are willing to face the uncertainty and challenges of a clinical trial to seek a better result.
Insurance and the costs of clinical trials change depending upon location and by study. Some of the expenses from participating in the clinical trial are reimbursed in several programs.
Clinical trials also have specific “eligibility criteria” rules that help research patients be safe. You and your research team carefully review these criteria together. People participating in a clinical trial can stop participating at any time for any medical or personal reasons. The reasons may include that the new treatment is not working or has severe side effects. Experts keep an eye on clinical trials for any problems with each study.
- 1.Kim HJ, Bains MS. Randomized Clinical Trials in Esophageal Cancer. Surgical Oncology Clinics of North America. Published online January 2002:89-109. doi:10.1016/s1055-3207(03)00076-0
- 2.Vasson MP, Talvas J, Perche O, et al. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: A randomized clinical trial. Clinical Nutrition. Published online April 2014:204-210. doi:10.1016/j.clnu.2013.06.008